Wedmont Private Capital Danaher Corp Transaction History

Wedmont Private Capital

$1.75 Billion
Q3 2024

A detailed history of Wedmont Private Capital transactions in Danaher Corp stock. As of the latest transaction made, Wedmont Private Capital holds 5,389 shares of DHR stock, worth $1.26 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

5,389

Previous 4,736 13.79%

Holding current value

$1.26 Million

Previous $1.18 Million 26.63%

% of portfolio

0.09%

Previous 0.07%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$239.25 - $280.76 $156,230 - $183,336	653 Added 13.79%	5,389 $1.5 Million
Q2 2024 Jul 15, 2024	BUY	$235.51 - $267.98 $81,250 - $92,453	345 Added 7.86%	4,736 $1.18 Million
Q1 2024 Apr 10, 2024	BUY	$224.58 - $256.19 $125,989 - $143,722	561 Added 14.65%	4,391 $1.1 Million
Q4 2023 Jan 09, 2024	BUY	$185.1 - $233.13 $69,227 - $87,190	374 Added 10.82%	3,830 $886,000
Q3 2023 Oct 10, 2023	BUY	$233.08 - $265.59 $424,438 - $483,639	1,821 Added 111.38%	3,456 $857,000
Q2 2023 Jul 17, 2023	SELL	$224.99 - $256.14 $217,790 - $247,943	-968 Reduced 37.19%	1,635 $392,000
Q1 2023 Apr 11, 2023	SELL	$239.75 - $277.0 $669,382 - $773,384	-2,792 Reduced 51.75%	2,603 $656,000
Q4 2022 Jan 09, 2023	BUY	$241.42 - $282.29 $434,073 - $507,557	1,798 Added 49.99%	5,395 $0
Q3 2022 Oct 03, 2022	BUY	$247.06 - $1507.4 $221,859 - $1.35 Million	898 Added 33.27%	3,597 $929,000
Q2 2022 Jul 11, 2022	BUY	$237.11 - $299.66 $211,502 - $267,296	892 Added 49.36%	2,699 $684,000
Q1 2022 Apr 05, 2022	BUY	$257.27 - $315.76 $75,637 - $92,833	294 Added 19.43%	1,807 $523,000
Q4 2021 Jan 14, 2022	BUY	$292.08 - $329.01 $441,917 - $497,792	1,513 New	1,513 $442,000

Others Institutions Holding DHR

# of Institutions

2,507

Shares Held

542M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $170B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedmont Private Capital, based on Form 13F filings with the SEC.

News

Stay updated on Wedmont Private Capital with notifications on news.

Account

Wedmont Private Capital Danaher Corp Transaction History